CIK 0001830214
- Accelerated filer
Ginkgo Bioworks Holdings, Inc.
Sign in to watch- Ticker
- DNA
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 872652913
- Phone
- +1 877-442-5362
- Business address
- 27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA, 02210
- Former names
- Soaring Eagle Acquisition Corp., Spinning Eagle Acquisition Corp.
- 4 Planned sale 10% owner sold 75,300 shares at an average $1.94 ($146,082)
- 4 Planned sale See remarks sold 75,300 shares at an average $1.94 ($146,082)
- 4 Planned sale Director sold 39,007 shares at $1.84 ($71,773)
- 4 Planned sale See remarks sold 75,300 shares at an average $1.77 ($132,980)
- 4 Planned sale See remarks sold 200,000 shares at an average $1.77 ($353,200)
- 4 Planned sale 10% owner sold 75,300 shares at an average $1.77 ($132,980)
- 4 Planned sale Director sold 4,499 shares at $1.63 ($7,333)
- 4 Open-market sale See remarks sold 40,511 shares at $1.57 ($63,400)
- 4 Planned sale See remarks sold 75,300 shares at an average $1.64 ($123,116)
- 4 Planned sale See remarks sold 200,000 shares at an average $1.64 ($327,000)
- 4 Planned sale 10% owner sold 75,300 shares at an average $1.64 ($123,116)
- 4 Planned sale See remarks sold 75,300 shares at an average $1.54 ($116,075)
- 4 Planned sale 10% owner sold 75,300 shares at an average $1.54 ($116,075)
- 4 Planned sale See remarks sold 200,000 shares at an average $1.54 ($308,100)
- 4 Planned sale See remarks sold 250,000 shares at $1.50 ($375,000)
- 4 Open-market buy Director bought 400,000 shares at $1.28 ($512,000)
- 4 Open-market buy Director bought 350,000 shares at $1.28 ($448,000)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale See remarks sold 75,300 shares at an average $1.28 ($96,271)
- 4 Planned sale See remarks sold 200,000 shares at an average $1.28 ($255,700)
Page 11 of 24 · 474 filings